Weighted Average Number of Shares Outstanding, Basic of U S PHYSICAL THERAPY INC /NV from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: U S PHYSICAL THERAPY INC /NV quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
U S PHYSICAL THERAPY INC /NV Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 15,175,000, a 0.74% increase year-over-year.
U S PHYSICAL THERAPY INC /NV annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 15,175,000, a 0.74% increase from 2024.
U S PHYSICAL THERAPY INC /NV annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 15,064,000, a 6.2% increase from 2023.
U S PHYSICAL THERAPY INC /NV annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14,188,000, a 9.3% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

U S PHYSICAL THERAPY INC /NV Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	15,175,000	+111,000	+0.74%	01 Oct 2025	31 Dec 2025	10-K	27 Feb 2026	2025	FY
Q3 2025	15,204,000	+127,000	+0.84%	01 Jul 2025	30 Sep 2025	10-Q	07 Nov 2025	2025	Q3
Q2 2025	15,197,000	+125,000	+0.83%	01 Apr 2025	30 Jun 2025	10-Q	08 Aug 2025	2025	Q2
Q1 2025	15,132,000	+115,000	+0.77%	01 Jan 2025	31 Mar 2025	10-Q	09 May 2025	2025	Q1
Q4 2024	15,064,000	+876,000	+6.2%	01 Oct 2024	31 Dec 2024	10-K	27 Feb 2026	2025	FY
Q3 2024	15,077,000	+90,000	+0.6%	01 Jul 2024	30 Sep 2024	10-Q	07 Nov 2025	2025	Q3
Q2 2024	15,072,000	+1,352,000	+9.9%	01 Apr 2024	30 Jun 2024	10-Q	08 Aug 2025	2025	Q2
Q1 2024	15,017,000	+1,992,000	+15%	01 Jan 2024	31 Mar 2024	10-Q	09 May 2025	2025	Q1
Q4 2023	14,188,000	+1,203,000	+9.3%	01 Oct 2023	31 Dec 2023	10-K	27 Feb 2026	2025	FY
Q3 2023	14,987,000	+1,986,000	+15%	01 Jul 2023	30 Sep 2023	10-Q	08 Nov 2024	2024	Q3
Q2 2023	13,720,000	+722,000	+5.6%	01 Apr 2023	30 Jun 2023	10-Q	14 Aug 2024	2024	Q2
Q1 2023	13,025,000	+88,000	+0.68%	01 Jan 2023	31 Mar 2023	10-Q	08 May 2024	2024	Q1
Q4 2022	12,985,000	+87,000	+0.68%	01 Oct 2022	31 Dec 2022	10-K	03 Mar 2025	2024	FY
Q3 2022	13,001,000	+92,000	+0.71%	01 Jul 2022	30 Sep 2022	10-Q	08 Nov 2023	2023	Q3
Q2 2022	12,998,000	+96,000	+0.74%	01 Apr 2022	30 Jun 2022	10-Q	09 Aug 2023	2023	Q2
Q1 2022	12,937,000	+67,000	+0.52%	01 Jan 2022	31 Mar 2022	10-Q	05 May 2023	2023	Q1
Q4 2021	12,898,000	+63,000	+0.49%	01 Oct 2021	31 Dec 2021	10-K	29 Feb 2024	2023	FY
Q3 2021	12,909,000	+62,000	+0.48%	01 Jul 2021	30 Sep 2021	10-Q	08 Nov 2022	2022	Q3
Q2 2021	12,902,000	+59,000	+0.46%	01 Apr 2021	30 Jun 2021	10-Q	08 Aug 2022	2022	Q2
Q1 2021	12,870,000	+74,000	+0.58%	01 Jan 2021	31 Mar 2021	10-Q	09 May 2022	2022	Q1
Q4 2020	12,835,000			01 Oct 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
Q3 2020	12,847,000			01 Jul 2020	30 Sep 2020	10-Q	09 Nov 2021	2021	Q3
Q2 2020	12,843,000			01 Apr 2020	30 Jun 2020	10-Q	09 Aug 2021	2021	Q2
Q1 2020	12,796,000			01 Jan 2020	31 Mar 2020	10-Q	10 May 2021	2021	Q1
Q3 2017	12,581,000	+61,000	+0.49%	01 Jul 2017	30 Sep 2017	10-Q	07 Nov 2017	2017	Q3
Q2 2017	12,579,000	+68,000	+0.54%	01 Apr 2017	30 Jun 2017	10-Q	07 Aug 2017	2017	Q2
Q1 2017	12,528,000	+80,000	+0.64%	01 Jan 2017	31 Mar 2017	10-Q	29 Jun 2017	2017	Q1
Q4 2016	12,500,000	+79,000	+0.64%	01 Oct 2016	31 Dec 2016	10-K	07 Jun 2017	2016	FY
Q3 2016	12,520,000	+99,000	+0.8%	01 Jul 2016	30 Sep 2016	10-Q	07 Nov 2017	2017	Q3
Q2 2016	12,511,000	+102,000	+0.82%	01 Apr 2016	30 Jun 2016	10-Q	07 Aug 2017	2017	Q2
Q1 2016	12,448,000	+135,000	+1.1%	01 Jan 2016	31 Mar 2016	10-Q	29 Jun 2017	2017	Q1
Q4 2015	12,421,000	+154,000	+1.3%	01 Oct 2015	31 Dec 2015	10-K	04 Mar 2016	2015	FY
Q3 2015	12,421,000	+177,000	+1.4%	01 Jul 2015	30 Sep 2015	10-K	07 Jun 2017	2016	FY
Q2 2015	12,409,000	+185,000	+1.5%	01 Apr 2015	30 Jun 2015	10-K	07 Jun 2017	2016	FY
Q1 2015	12,313,000	+184,000	+1.5%	01 Jan 2015	31 Mar 2015	10-K	07 Jun 2017	2016	FY
Q4 2014	12,267,000	+164,000	+1.4%	01 Oct 2014	31 Dec 2014	10-K	04 Mar 2016	2015	FY
Q3 2014	12,244,000	+138,000	+1.1%	01 Jul 2014	30 Sep 2014	10-K	04 Mar 2016	2015	FY
Q2 2014	12,224,000	+135,000	+1.1%	01 Apr 2014	30 Jun 2014	10-K	04 Mar 2016	2015	FY
Q1 2014	12,129,000	+174,000	+1.5%	01 Jan 2014	31 Mar 2014	10-K	04 Mar 2016	2015	FY
Q4 2013	12,103,000	0	0%	01 Oct 2013	31 Dec 2013	10-K	12 Mar 2015	2014	FY
Q3 2013	12,106,000	0	0%	01 Jul 2013	30 Sep 2013	10-K	12 Mar 2015	2014	FY
Q2 2013	12,089,000	0	0%	01 Apr 2013	30 Jun 2013	10-K	12 Mar 2015	2014	FY
Q1 2013	11,955,000	0	0%	01 Jan 2013	31 Mar 2013	10-K	12 Mar 2015	2014	FY
Q4 2012	12,103,000	+317,000	+2.7%	01 Oct 2012	31 Dec 2012	10-K	11 Mar 2014	2013	FY
Q3 2012	12,106,000	+220,000	+1.9%	01 Jul 2012	30 Sep 2012	10-K	11 Mar 2014	2013	FY
Q2 2012	12,089,000	+282,000	+2.4%	01 Apr 2012	30 Jun 2012	10-K	11 Mar 2014	2013	FY
Q1 2012	11,955,000	+237,000	+2%	01 Jan 2012	31 Mar 2012	10-K	11 Mar 2014	2013	FY
Q4 2011	11,786,000			01 Oct 2011	31 Dec 2011	10-K	12 Mar 2013	2012	FY
Q3 2011	11,886,000	+219,000	+1.9%	01 Jul 2011	30 Sep 2011	10-K	12 Mar 2013	2012	FY
Q2 2011	11,807,000	+185,000	+1.6%	01 Apr 2011	30 Jun 2011	10-K	12 Mar 2013	2012	FY
Q1 2011	11,718,000			01 Jan 2011	31 Mar 2011	10-K	12 Mar 2013	2012	FY
Q3 2010	11,667,000			01 Jul 2010	30 Sep 2010	10-Q	08 Nov 2011	2011	Q3
Q2 2010	11,622,000			01 Apr 2010	30 Jun 2010	10-Q	04 Aug 2011	2011	Q2

U S PHYSICAL THERAPY INC /NV Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	15,175,000	+111,000	+0.74%	01 Jan 2025	31 Dec 2025	10-K	27 Feb 2026	2025	FY
2024	15,064,000	+876,000	+6.2%	01 Jan 2024	31 Dec 2024	10-K	27 Feb 2026	2025	FY
2023	14,188,000	+1,203,000	+9.3%	01 Jan 2023	31 Dec 2023	10-K	27 Feb 2026	2025	FY
2022	12,985,000	+87,000	+0.68%	01 Jan 2022	31 Dec 2022	10-K	03 Mar 2025	2024	FY
2021	12,898,000	+63,000	+0.49%	01 Jan 2021	31 Dec 2021	10-K	29 Feb 2024	2023	FY
2020	12,835,000	+79,000	+0.62%	01 Jan 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
2019	12,756,000			01 Jan 2019	31 Dec 2019	10-K	01 Mar 2022	2021	FY
2016	12,500,000	+108,000	+0.87%	01 Jan 2016	31 Dec 2016	10-K	07 Jun 2017	2016	FY
2015	12,392,000	+175,000	+1.4%	01 Jan 2015	31 Dec 2015	10-K	07 Jun 2017	2016	FY
2014	12,217,000	+154,000	+1.3%	01 Jan 2014	31 Dec 2014	10-K	07 Jun 2017	2016	FY
2013	12,063,000	+259,000	+2.2%	01 Jan 2013	31 Dec 2013	10-K	04 Mar 2016	2015	FY
2012	11,804,000	-10,000	-0.08%	01 Jan 2012	31 Dec 2012	10-K	12 Mar 2015	2014	FY
2011	11,814,000	+176,000	+1.5%	01 Jan 2011	31 Dec 2011	10-K	11 Mar 2014	2013	FY
2010	11,638,000			01 Jan 2010	31 Dec 2010	10-K	12 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.